ECS Botanics Holdings Ltd Stock Price Today (NSE: ECS)

ECS Botanics Holdings Ltd

11.99+0.00 (+0.00%)
Market Closed

Fundamental Score

...

ECS Botanics Holdings Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

ECS Botanics Holdings Ltd share price today is 11.99, up +0.00% on NSE/BSE as of 1 August 2026. ECS Botanics Holdings Ltd (ECS) is a Small-cap company in the Computers - Software & Consulting sector with a market capitalisation of 24.67 (Cr). The 52-week high for ECS share price is 12.81 and the 52-week low is 6.32. At a P/E ratio of 822.33x, ECS is currently trading above its industry average P/E of 22.33x.

ECS Botanics Holdings Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
12.58
Low
10.40
Volume
7.0K
Change
+15.29%

ECS Botanics Holdings Ltd share price chart: 15.29% return over the past month. 52-week high ₹12.81, 52-week low ₹6.32.

ECS Botanics Holdings Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
11.9911.9911.9911.990.00 (Cr)
11.9911.9911.9911.990.00 (Cr)
11.9911.9911.9911.990.00 (Cr)
11.9911.9911.9911.990.00 (Cr)
11.9911.9911.9911.990.00 (Cr)
11.9911.9911.9911.990.00 (Cr)
11.9911.9911.9911.990.00 (Cr)
11.9911.9911.9911.990.00 (Cr)
11.9911.9911.9911.99100.00 (Cr)
12.0012.0012.0012.000.00 (Cr)

ECS Botanics Holdings Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
10.9212.5810.8511.99+9.80%
10.0011.579.4410.40+4.00%
8.6910.637.1510.19+17.26%
11.3311.338.698.69-23.30%
10.9012.6610.8311.33+3.94%
7.0011.056.3211.05+57.86%
12.1912.197.577.73-36.59%
12.1712.1911.5912.19+0.16%
9.0312.817.3212.81+41.86%
9.1012.018.308.95-1.65%
8.489.458.069.00+6.13%
8.5810.307.878.48-1.17%

AI Research Briefing

Powered by Gemini · 2026-08-01

Pure reverse-merger takeover trade on an illiquid shell stock with non-existent earnings and an 822x P/E multiplier.

Research Confidence
4.5/10Low
MICRO-CAP DARK HORSEStrong speculative momentum with 1M (+8.89%), 3M (+23.33%), and 1Y (+45.45%) driven by corporate action.Extremely expensive at 822.33x P/E vs industry benchmark 22.33x.

WHAT'S HAPPENING NOW (last 2-4 weeks)

On July 29, 2026, Rakesh Ramanlal Shah and Komal Infotech executed a Share Purchase Agreement to acquire a 65.42% controlling stake (1.34 crore shares) from outgoing promoter Vijay Mansinhbhai Mandora for ₹3.03 crore. The deal triggered a mandatory SEBI SAST open offer to buy up to 26% public float at ₹10.50 per share, representing a total cash consideration of ₹5.61 crore. Previously on June 12, 2026, BSE approved the reclassification of eight promoter group members to the public category. Full year FY26 revenues slumped 34.9% YoY to ₹1.90 crore, leaving net profit at a tiny ₹0.03 crore.

CORE STORY (THE REAL GAME)

This is a reverse-merger shell takeover play, not an IT consulting turnaround story. Outgoing promoters are executing a complete exit by selling controlling interest. Markets are pricing the potential injection of new private IT assets or capital by the incoming acquirer into a clean, debt-free listed vehicle.

Why Now
  • Incoming promoter deal on July 29, 2026: Rakesh Shah signed SPA to acquire 65.42% stake for ₹3.03 crore.
  • Mandatory 26% open offer triggered at ₹10.50 per share with ₹5.61 crore cash commitment.
  • FY26 full-year revenue collapsed 34.9% YoY to ₹1.90 crore, confirming core operations have bottomed out.
Potential Catalysts
  • Detailed Public Statement (DPS) publication for the open offer expected by August 5, 2026.
  • Concrete announcement of new IT/tech asset injection by incoming acquirers Komal Infotech.
  • Completion of management transition and strategic turnaround roadmap post-takeover.
Key Risks
  • Extreme valuation stretch with trailing P/E of 822.33x against industry benchmark of 22.33x.
  • Micro-cap illiquidity risk with ₹24.67 Cr market cap, making it prone to pump-and-dump operator traps.
  • Decaying core business fundamentals with full-year FY26 sales down 34.9% YoY to ₹1.90 Cr.
Institutional Activity

Existing promoters sold out their complete 65.42% stake; zero FII and zero DII holding.

Macro Context

Macro headwinds in IT consulting hit micro-cap vendors hardest as enterprise clients consolidate vendor lists.

Order Book / Expansion

No client order wins found; recent disclosures dominated by the July 29, 2026 acquisition deal for ₹3.03 Cr and ₹5.61 Cr open offer.

Cash Flow Quality

Yes, 5-year FCF stands at ₹5.96 Cr, but recent operational cash flows are negligible due to revenue contraction.

3–6 Month Outlook

High volatility over 3-6 months as open offer closes; direction depends entirely on incoming management capability.

Primary Thesis Risk

Post-open offer crash if incoming promoters fail to inject revenue-generating IT assets.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Return on Equity (ROE)

N/A

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

7.05%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

8.38%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

ECS Botanics Holdings Ltd Valuation Check

Poor

Price to Earnings (P/E)

822.33x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

22.33x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

65.42%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

0.00%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

-23.26%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

4.56%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

15.00%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

15.00%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Debt to Equity Ratio

N/A

Total debt ÷ equity. Below 0.5 = financially healthy

Interest Coverage Ratio

N/A

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

5.96 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

ECS Botanics Holdings Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of ECS across key market metrics for learning purposes.

Positive Indicators

4 factors identified

Excellent EPS Growth (15.00% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (15.00% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Balanced Promoter Holding (65.42%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

5 factors identified

Suboptimal ROCE (7.05%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Premium Valuation Risk (P/E: 822.33x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Revenue Contraction (-23.26%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions.

Limited Growth History (4.56% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

ECS Botanics Holdings Ltd vs Computers - Software & Consulting Peers

Peer Comparison - Computers - Software & Consulting

Compare ECS Botanics Holdings Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
23.6/100
12
₹24.67
822.3
Average
7.05%
Poor
15.00%
Excellent
4.56%
Average
0.00%
65.4/100
2366
₹791945.76
14.8
Average
51.81%
Excellent
63.03%
Excellent
0.1
Excellent
9.45%
Good
10.22%
Good
2.92%
60.4/100
1130
₹437177.23
14.5
Average
31.89%
Excellent
39.95%
Excellent
0.1
Excellent
9.29%
Good
12.20%
Good
4.46%
65.8/100
1347
₹316874.61
17.5
Average
23.98%
Excellent
30.60%
Excellent
0.1
Excellent
9.57%
Good
11.54%
Good
4.62%
Wipro Ltd...
WIPRO507685
49.2/100
176
₹173010.39
13.1
Average
15.46%
Good
17.84%
Good
0.2
Excellent
4.05%
Average
8.38%
Good
6.30%
41.9/100
1651
₹146940.68
29.4
Average
17.53%
Good
23.12%
Excellent
0.1
Excellent
2.44%
Average
8.46%
Good
3.40%
74.7/100
4381
₹120235.26
21.4
Average
23.13%
Excellent
29.60%
Excellent
0.1
Excellent
22.79%
Excellent
27.88%
Excellent
1.85%
63.8/100
5549
₹80072.30
41.5
Average
27.24%
Excellent
34.36%
Excellent
0.1
Excellent
35.85%
Excellent
28.63%
Excellent
0.69%
69.2/100
1721
₹67910.23
41.4
Average
20.64%
Excellent
23.50%
Excellent
0.1
Excellent
28.45%
Excellent
28.60%
Excellent
0.99%
Mphasis Ltd...
MPHASIS526299
46/100
2342
₹44659.24
23.6
Average
18.53%
Good
22.09%
Excellent
0.2
Excellent
9.19%
Good
10.31%
Good
2.65%
58.6/100
562
₹34454.91
23.5
Average
24.86%
Excellent
30.07%
Excellent
0.1
Excellent
18.49%
Excellent
16.49%
Excellent
2.04%

ECS Botanics Holdings Ltd PE Ratio History

Historical price-to-earnings ratio for ECS — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20241.37₹10.437.6x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

ECS Botanics Holdings Ltd Quarterly Performance

Latest quarterly metrics for ECS — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

-23.26%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

0.00%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

4.56%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

15.00%

Compounded annual net profit growth over 5 years

ECS Botanics Holdings Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for ECS — calculated from daily price history

50RSI 14
Neutral — RSI 50

Momentum is balanced — neither overbought nor oversold.

SMA 50
11
▲ Price above SMA 50 — Short-term bullish
SMA 200
10
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
6K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

ECS Botanics Holdings Ltd Financial Statements

Annual income statement, balance sheet and cash flow for ECS Botanics Holdings Ltd (ECS) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for ECS Botanics Holdings Ltd

About ECS (ECS Botanics Holdings Ltd)

ECS Botanics Holdings Ltd is carving a niche for itself in the burgeoning field of agricultural technology, offering software and consulting services specifically designed for the ...burgeoning cannabis and hemp industries. ECS leverages sophisticated data analytics platforms to provide growers with invaluable insights into optimizing cultivation practices, from precise environmental controls and irrigation strategies to predicting yield outputs and mitigating potential crop diseases. Their software solutions enable seamless tracking of plants throughout the entire lifecycle, from seed to sale, ensuring regulatory compliance and streamlining supply chain management. Beyond software, ECS consultants provide tailored guidance on navigating the complex landscape of cannabis cultivation licensing, operational efficiency, and risk management, empowering businesses to thrive in a rapidly evolving market. The company's commitment extends beyond simply maximizing yield. ECS emphasizes sustainable and environmentally conscious cultivation practices by integrating resource management tools into its software platform. These tools monitor water usage, energy consumption, and waste disposal, allowing cultivators to minimize their environmental footprint and operate more responsibly. This eco-conscious approach aligns with the growing consumer demand for sustainably produced cannabis and hemp products, giving ECS clients a competitive edge in the marketplace. Furthermore, ECS offers comprehensive data security solutions tailored to the unique needs of the cannabis industry, protecting sensitive information from cyber threats and ensuring the integrity of their clients' operations. Ultimately, ECS aims to be a transformative partner for businesses in the cannabis and hemp sectors. By providing cutting-edge software and expert consulting services, ECS empowers growers, processors, and retailers to optimize their operations, reduce costs, and navigate the complexities of a highly regulated industry. The company’s dedication to innovation, sustainability, and data security positions them as a key player in shaping the future of agricultural technology, fostering a more efficient, transparent, and environmentally responsible cannabis and hemp ecosystem. ECS envisions a future where technology empowers businesses to unlock the full potential of these valuable crops while adhering to the highest ethical and environmental standards.

Company Details

Symbol:ECS
Industry:Computers - Software & Consulting
Sector:Computers - Software & Consulting

Key Leadership

Mr. Vijay Mansinhbhai Mandora
Executive Chairman & MD
Ms. Nilam Viren Makwana
Whole-Time Company Secretary & Compliance Officer

ECS Share Price: Frequently Asked Questions

What is the current share price of ECS Botanics Holdings Ltd?

ECS Botanics Holdings Ltd (ECS) trades at ₹11.99 on NSE and BSE. Market cap ₹24.67 (Cr). Educational data only.

What is the P/E ratio of ECS Botanics Holdings Ltd?

ECS Botanics Holdings Ltd has a P/E of 822.33x vs industry average 22.33x.

What is the Bull Run score for ECS Botanics Holdings Ltd?

ECS Botanics Holdings Ltd has a Bull Run score of 23.6/100 based on 25+ financial parameters.

Does ECS Botanics Holdings Ltd pay dividends?

ECS Botanics Holdings Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of ECS Botanics Holdings Ltd?

ECS Botanics Holdings Ltd has ROE of N/A. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of ECS Botanics Holdings Ltd?

ECS Botanics Holdings Ltd has debt-to-equity of N/A.

Is ECS Botanics Holdings Ltd a good investment?

Bull Run gives ECS Botanics Holdings Ltd a score of 23.6/100. This is not investment advice — consult a SEBI-registered advisor.